ReviewImmunotherapy advances2022

Plasma exchange for severe immune-related adverse events from checkpoint inhibitors: an early window of opportunity?

Tamiko R Katsumoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.